| Regulating Emotions and Behaviors After Brain Injury (NCT05393492) | University Hospital, Strasbourg, France | 2022-05-19 |
| Meningococcal Serogroup ACYWX Conjugate Vaccine in Comparison With MenACWY-TT Conjugate Vaccine (NCT05093829) | Emory University | 2022-03-24 |
| Validation of a Predictive Rule for the Diagnosis of Viral Meningitis in Adult Emergency Departments (NCT05062642) | Centre Hospitalier le Mans | 2021-08-26 |
| The Clinical Character，Risk and Prognosis of Post-neurosurgical Intracranial Infection With Different Pathogens. (NCT04917380) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2021-06-10 |
| Optimal Encephalitis/Meningitis Roadmap Via Precise Diagnosis and Treatment (NCT04946682) | Wen-hong Zhang | 2021-04-14 |
| BIGlobal Intervention Study: Improving Diagnosis and Management of Suspected Brain Infections Globally (NCT04190303) | University of Liverpool | 2021-02-17 |
| Host RNA Profiles to Detect Infections in Young Infants (NCT04823026) | Rigshospitalet, Denmark | 2020-05-15 |
| Persistence of Immunogenicity Following Reduced PCV Dosing Schedules in South African Children (NCT04275284) | University of Witwatersrand, South Africa | 2020-02-14 |
| The Effect of Supraglottic and Oropharyngeal Decontamination on the Incidence of Ventilator-associated Pneumonia (NCT04325685) | Northern State Medical University | 2020-01-01 |
| Epidemiological, Clinical, Microbiological and Outcome Description of Patients With Klebsiella sp Meningitis (NCT03967210) | Fondation Hôpital Saint-Joseph | 2019-07-05 |
| Brazil ICU Encephalitis Surveillance (NCT05370573) | D'Or Institute for Research and Education | 2019-06-01 |
| Paediatric Infections Point-Of-Care (NCT03900091) | Karolinska Institutet | 2019-04-01 |
| Repeat Lumbar Puncture at 24 Versus 48 Hours After Traumatic Lumbar Puncture in Neonates (NCT04794881) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2019-03-18 |
| Neurology Inpatient Clinical Education Trial (NCT03826056) | Dartmouth-Hitchcock Medical Center | 2019-02-01 |
| Pediatric Infectious Disease Precision Medicine Using Sequencing Evaluation of CSF (NCT03796546) | IDbyDNA, Inc. | 2019-01-22 |
| Maternal Immunization With MenAfriVac™ (NCT03746665) | London School of Hygiene and Tropical Medicine | 2018-12-19 |
| Increasing Healthcare Engagement Via Routine Vaccination Among Young Black Men Who Have Sex With Men (NCT03445416) | Ann & Robert H Lurie Children's Hospital of Chicago | 2018-09-01 |
| The Effectiveness and Safety of Human Lumbar Puncture Assist Device (LPat) (NCT03710278) | Spartanburg Regional Healthcare System | 2017-12-21 |
| Petechiae In Children (PIC) Study: Defining A Clinical Decision Rule for The Management Of Fever and Non-Blanching Rashes In Children Including The Role Of Point Of Care Testing For Procalcitonin & Neisseria Meningitidis DNA. (NCT03378258) | Belfast Health and Social Care Trust | 2017-11-09 |
| Combined Intracerebral and Jugular Bulb Microdialysis (NCT03314779) | Odense University Hospital | 2017-08-28 |
| Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Toddlers (NCT02955797) | Sanofi Pasteur, a Sanofi Company | 2017-02-24 |
| Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Children Aged 2 to 9 Years (NCT03077438) | Sanofi Pasteur, a Sanofi Company | 2017-02-17 |
| Reduced PCV Dosing Schedules in South African Infants (NCT02943902) | University of Witwatersrand, South Africa | 2017-01-09 |
| Hypovitaminosis D in Neurocritical Patients (NCT02881957) | University of Utah | 2016-10-10 |
| Immunogenicity and Safety of Meningococcal Groups A and C and Haemophilus b Conjugate Vaccine in Infants 2 to 5 Months of Age (NCT02919293) | Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd | 2016-08-01 |
| Postmarketing Surveillance Study for Use of Menactra® in the Republic of Korea (NCT02864927) | Sanofi Pasteur, a Sanofi Company | 2016-07-21 |
| Immune Lot Consistency, Immunogenicity, and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine (NCT02842853) | Sanofi Pasteur, a Sanofi Company | 2016-07-15 |
| Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adults 56 Years and Older (NCT02842866) | Sanofi Pasteur, a Sanofi Company | 2016-07-15 |
| Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam (NCT02640404) | Sanofi Pasteur, a Sanofi Company | 2016-06-06 |
| Precision Diagnosis of Acute Infectious Diseases; Neuroinflammatory Cohort (NCT02910037) | University of California, San Francisco | 2016-06-01 |
| Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine (NCT02752906) | Sanofi Pasteur, a Sanofi Company | 2016-04-15 |
| Host-pathogen Interactions in Meningococcal Disease: Finding the Key That Fits the Lock (NCT02727465) | Public Health England | 2016-03-01 |
| Observational Safety Study of Menactra® Administered Under Standard Health Care Practice in the Russian Federation (NCT02699840) | Sanofi Pasteur, a Sanofi Company | 2016-02-01 |
| Neurologic Manifestations of the Arbovirus Infection in Colombia (NCT03206541) | Johns Hopkins University | 2016-01-01 |
| Persistence of Bactericidal Antibodies in Adults Who Received a Booster Dose of Menactra® Approximately 4 Years Earlier (NCT02633787) | Sanofi Pasteur, a Sanofi Company | 2015-12-01 |
| Immunogenicity and Safety of Two-Dose Series of Menactra® in Japanese Healthy Adult Subjects (NCT02591290) | Sanofi Pasteur, a Sanofi Company | 2015-10-20 |
| Penetration of Ceftaroline Into Cerebrospinal Fluid(CSF) (NCT02806882) | Centre Hospitalier Universitaire Dijon | 2015-04-29 |
| Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Toddlers (NCT03205358) | Sanofi Pasteur, a Sanofi Company | 2015-03-31 |
| Central Nervous System Infections in Denmark (NCT03418441) | Aalborg University Hospital | 2015-01-01 |
| Diagnostic Performance of Clinical Signs Patients Suspected of Meningitis to Emergencies (NCT02841254) | Nantes University Hospital | 2014-11-01 |
| Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Healthy Adolescents (NCT02199691) | Sanofi Pasteur, a Sanofi Company | 2014-07-22 |
| Investigating the Immune Response to 4CMenB in Infants (NCT02080559) | University of Oxford | 2014-07-21 |
| Stem Cell Transplantation In-patient With Neurological Sequelae Due to Encephalitis or Meningitis (NCT04080921) | Vinmec Research Institute of Stem Cell and Gene Technology | 2014-06-16 |
| Understanding Pneumococcal Carriage and Disease (NCT01996007) | University of Oxford | 2014-03-01 |
| Feeding Bovine Colostrum to Preterm Infants (NCT02054091) | Per Torp Sangild | 2014-02-01 |
| Immunogenicity and Safety of Group A, C, Y and W135 Meningococcal Polysaccharide Vaccine (NCT02003313) | Beijing Minhai Biotechnology Co., Ltd | 2013-11-01 |
| Immunogenicity and Safety of Meningococcal (A, C, Y and W135) Conjugate Vaccine (NCT02003495) | Beijing Minhai Biotechnology Co., Ltd | 2013-10-01 |
| Pertussis and Meningitis C Concomitant Vaccination in Adolescents (NCT02526394) | Public Health England | 2013-09-01 |
| Immunogenicity and Safety of Menactra® Vaccine in Subjects Aged 9 to 23 Months in India and in the Russian Federation (NCT01890759) | Sanofi Pasteur, a Sanofi Company | 2013-06-25 |
| Nervous System Infections Among Patients With Febrile Seizure (NCT01694524) | Hôpital Armand Trousseau | 2013-06-01 |
| Improving the Diagnosis of Meningitis in Emergency Rooms (NCT02858661) | Assistance Publique Hopitaux De Marseille | 2013-03-30 |
| Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days of Age With Probable and Confirmed Meningitis (NCT01554124) | PENTA Foundation | 2013-02-01 |
| Optimising Diagnosis and Antibiotic Prescribing for Acutely Ill Children in Primary Care (NCT02024282) | KU Leuven | 2013-01-01 |
| Pharmacological Study of High Doses of Ceftriaxone in Meningitidis (NCT01745679) | Nantes University Hospital | 2012-12-01 |
| Understanding the Immune Response to Two Different Meningitis Vaccines (NCT01593514) | University of Oxford | 2012-12-01 |
| Study of a Quadrivalent Meningococcal Conjugate Vaccine in Subjects Aged 56 and Older (NCT01732627) | Sanofi Pasteur, a Sanofi Company | 2012-11-12 |
| Lumbar Punctures in Neonates: Improving Success Rates and Minimizing Pain (NCT01606150) | Georgetown University | 2012-11-01 |
| Study of Menactra® in Healthy Subjects at 9 Months and Concomitantly With Pentacel® at 15 to 18 Months of Age (NCT01659996) | Sanofi Pasteur, a Sanofi Company | 2012-07-01 |
| Safety and Immunogenicity Study for Use of Menactra® Versus Adacel® in Subjects 11 to 55 Years of Age in South Korea (NCT01642589) | Sanofi Pasteur, a Sanofi Company | 2012-07-01 |
| Phase 3 Study of A Group A, C Polysaccharide Meningococcal and Type b Haemophilus Influenzal Conjugate Vaccine (NCT01580033) | Jiangsu Province Centers for Disease Control and Prevention | 2012-04-01 |
| Daptomycin in Pediatric Patients With Bacterial Meningitis (NCT01522105) | Insel Gruppe AG, University Hospital Bern | 2012-04-01 |
| A Study of Doripenem in CerebrospinalFluid After Doripenem Administration in Pediatric Patients Less Than 1 Year of Age (NCT01366651) | Janssen Research & Development, LLC | 2012-03-01 |
| Study of a Single Dose of Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine (SP284) in Japanese Subjects (NCT01519713) | Sanofi Pasteur, a Sanofi Company | 2012-01-01 |
| Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children (NCT01619462) | Papua New Guinea Institute of Medical Research | 2011-11-01 |
| Study of a Single Dose of Menactra® Vaccine 4-6 Years After Prior Menactra Vaccine (NCT01442675) | Sanofi Pasteur, a Sanofi Company | 2011-09-01 |
| Study of Sanofi Pasteur and Lanzhou Institute's Meningococcal (Group A and C) Polysaccharide Vaccine in Children (NCT01430611) | Sanofi Pasteur, a Sanofi Company | 2011-08-01 |
| Post-licensure Safety Surveillance Study of Menactra Vaccine When Administered As a 2-dose Schedule to Children (NCT01689155) | Sanofi Pasteur, a Sanofi Company | 2011-06-01 |
| Study of Two Doses of Menactra® or One Dose of Monovalent Meningococcal Group C Vaccine With Routine Immunizations (NCT01359449) | Sanofi Pasteur, a Sanofi Company | 2011-05-01 |
| A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years. (NCT01323270) | Pfizer | 2011-03-18 |
| Validation of Vital Signs and Symptoms for the Diagnosis of Serious Infections in Children in the Paediatric A&E. (NCT01396798) | KU Leuven | 2011-02-01 |
| Post-Marketing Safety Study of Menactra® in Healthy Children, Adolescents, and Adults in the Philippines (NCT01270503) | Sanofi Pasteur, a Sanofi Company | 2010-12-01 |
| Antibody Persistence and Response to Re-vaccination With Either Menactra® or Menomune® 3 Years After Initial Vaccination (NCT01239043) | Sanofi | 2010-11-01 |
| A Study of Meningococcal Vaccine, Menactra® in Healthy Subjects in India (NCT01086969) | Sanofi | 2010-06-01 |
| Study on the Impact of Vaccination With a Conjugate Vaccine on Meningococcal Carriage (NCT01119482) | London School of Hygiene and Tropical Medicine | 2010-05-01 |
| Cerebrospinal Fluid Pharmacokinetics of Daptomycin (NCT01025271) | University of Pittsburgh | 2010-05-01 |
| A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers (NCT01049035) | Sanofi Pasteur, a Sanofi Company | 2009-12-16 |
| Understanding the Immune Response to Meningitis Vaccines (NCT00901940) | University of Oxford | 2009-06-01 |
| Treatment of West Nile Virus With MGAWN1 (NCT00927953) | MacroGenics | 2009-05-01 |
| Study to Evaluate the Safety of Novartis MenACWY Conjugate Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants (NCT00806195) | Novartis | 2008-12-01 |
| Persistence of Bactericidal Antibodies in Adolescents and Adults Who Had Received a Single Dose of Menactra® Vaccine (NCT00862277) | Sanofi Pasteur, a Sanofi Company | 2008-12-01 |
| Procalcitonin Level and Kinetics in Children With Bacterial Infections (NCT00714402) | Shaare Zedek Medical Center | 2008-08-01 |
| Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26 (NCT00700713) | Sanofi Pasteur, a Sanofi Company | 2008-06-01 |
| Dose Comparison Study of Menactra® in US Children (NCT00700635) | Sanofi Pasteur, a Sanofi Company | 2008-06-01 |
| Safety and Immunogenicity of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Toddlers (NCT00631995) | Sanofi Pasteur, a Sanofi Company | 2008-04-01 |
| Immunology and Safety of Menactra® in Children in Saudi Arabia (NCT00539032) | Sanofi Pasteur, a Sanofi Company | 2007-09-01 |
| Cotrimoxazole Versus Vancomycin for Invasive Methicillin-resistant Staphylococcus Aureus Infections (NCT00427076) | Rabin Medical Center | 2007-06-01 |
| Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth (NCT00459316) | National Institute of Allergy and Infectious Diseases (NIAID) | 2007-06-01 |
| Colombia Epidemiologic Surveillance Study (NCT00428051) | Pfizer | 2006-09-01 |
| Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 002 (NCT01661738) | Hualan Biological Engineering, Inc. | 2006-05-01 |
| Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 003 (NCT01661751) | Hualan Biological Engineering, Inc. | 2006-05-01 |
| Clinical Trial of Group ACYW135 Meningococcal Polysaccharide Vaccine 001 (NCT01661725) | Hualan Biological Engineering, Inc. | 2006-04-01 |
| Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025) (NCT00325130) | Merck Sharp & Dohme LLC | 2006-04-01 |
| Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune® (NCT00258856) | Sanofi Pasteur, a Sanofi Company | 2006-01-01 |
| Persistence of Antibodies in Adolescents and Adults 15 to 23 Years Who Received One Dose of Menactra® or Menomune® (NCT00269477) | Sanofi Pasteur, a Sanofi Company | 2005-12-01 |
| Lebanese Interhospital Pneumococcal Surveillance Program (NCT00901602) | American University of Beirut Medical Center | 2005-10-01 |
| Descriptive, Post-marketing, Surveillance Safety Study of Menactra Vaccine (NCT00254995) | Sanofi Pasteur, a Sanofi Company | 2005-07-01 |
| Neonatal Immunization With Pneumococcal Conjugate Vaccine in Papua New Guinea (NCT00219401) | Papua New Guinea Institute of Medical Research | 2005-05-01 |
| Study of Menactra® in US Adolescents When Administered Concomitantly With Tdap Vaccine (NCT00777257) | Sanofi Pasteur, a Sanofi Company | 2005-04-01 |
| Study of a Tetravalent Meningococcal Diphtheria Toxoid Conjugate Vaccine in Toddlers 9 to 18 Months of Age (NCT00643916) | Sanofi Pasteur, a Sanofi Company | 2004-12-01 |
| Does Static Ultrasound-Preview Reduce the Incidence of Difficult Lumbar Puncture? (NCT00317382) | St. Luke's-Roosevelt Hospital Center | 2004-12-01 |